載入...
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
The frequency of using rituximab to treat refractory nephrotic syndrome has recently been increasing, and the conventional dose of rituximab used to treat it, 375 mg/m2 body surface area once weekly for 4 weeks, has been modelled on the chemotherapy regimen for B-cell non-Hodgkin’s lymphoma. The dos...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Karger Publishers
2018-10-01
|
| 叢編: | Case Reports in Nephrology and Dialysis |
| 主題: | |
| 在線閱讀: | https://www.karger.com/Article/FullText/493189 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|